Rhinogram Named in the Capterra Shortlist Report
CHATTANOOGA, Tenn. – March 21, 2022 – Rhinogram, a leading cloud-based, HIPAA-compliant virtual care platform, announced today that it has been named a top Telemedicine software product by Capterra, a free online service that helps organizations find the right software.
“As healthcare continues to face staffing shortages, now is the time to implement a hybridized care approach. Telemedicine allows for convenience for the patient, and saves time and costs for the provider,” said Dr. Keith Dressler, chairman and chief executive officer of Rhinogram. “Telemedicine isn’t just being able to meet with live video, but leverages all channels of technology to walk along side the patient in their journey to health.”
Capterra Shortlist is an independent assessment that evaluates user reviews and online search activity to generate a list of market leaders in the Telemedicine space that offer the most popular solutions. The Telemedicine Shortlist report is available at https://www.capterra.com/ telemedicine-software/# shortlist.
To learn more about Rhinogram’s HIPAA-compliant, virtual care platform visit www.rhinogram.com or email hello@rhinogram.com.
About Rhinogram
Based in Chattanooga, Tenn., Rhinogram is a leading cloud-based, HIPAA-compliant virtual care platform – connecting patients, clinicians and office administrators through confidential text message, video interactions and encrypted phone calls in real time. The virtual care platform, which supports multimedia messaging and Facebook messenger communication, seamlessly integrates with most EHR and PMS systems, synchronizing encrypted patient communication into clinical workflows.
With Rhinogram, providers can better engage with their patients by streamlining administrative processes, managing pre- and post-procedure care, and reducing unnecessary appointments to realize value-based care success and deliver a quality experience that drives patient loyalty.
For more information, visit www.rhinogram.com and connect with us on Twitter, LinkedIn and Facebook.